South Korea Pharmacovigilance Market Size & Outlook

The pharmacovigilance market in South Korea is expected to reach a projected revenue of US$ 895.9 million by 2030. A compound annual growth rate of 8.2% is expected of South Korea pharmacovigilance market from 2025 to 2030.
Revenue, 2024 (US$M)
$549.7
Forecast, 2030 (US$M)
$895.9
CAGR, 2025 - 2030
8.2%
Report Coverage
South Korea

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Korea pharmacovigilance market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Korea pharmacovigilance market highlights

  • The South Korea pharmacovigilance market generated a revenue of USD 549.7 million in 2024 and is expected to reach USD 895.9 million by 2030.
  • The South Korea market is expected to grow at a CAGR of 8.2% from 2025 to 2030.
  • In terms of segment, phase 4 was the largest revenue generating product life cycle in 2024.
  • Phase 1 is the most lucrative product life cycle segment registering the fastest growth during the forecast period.

Pharmacovigilance market data book summary

Market revenue in 2024USD 549.7 million
Market revenue in 2030USD 895.9 million
Growth rate8.2% (CAGR from 2025 to 2030)
Largest segmentPhase 4
Fastest growing segmentPhase 1
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPhase 2, Phase 1, Phase 3, Phase 4, Pre Clinical
Key market players worldwideAccenture PLC Class A, IQVIA Holdings Inc, Cognizant Technology Solutions Corp Class A, Linical Americas, International Business Machines Corp, Labcorp Holdings Inc, ArisGlobal, Capgemini SE, ITClinical, Icon PLC, TAKE Solutions, PAREXEL, Wipro Ltd ADR, United Biosource Corporation, FMD K&L, BioClinica

Other key industry trends

  • In terms of revenue, South Korea accounted for 6.9% of the global pharmacovigilance market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China pharmacovigilance market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 340.5 million by 2030.

Phase 4 was the largest segment with a revenue share of 83.21% in 2024. Horizon Databook has segmented the South Korea pharmacovigilance market based on phase 2, phase 1, phase 3, phase 4, pre clinical covering the revenue growth of each sub-segment from 2018 to 2030.


The market growth can be attributed to the ease of access to pharmaceuticals, rising adoption of polypharmacy, expedited drug development, and rising prevalence of chronic diseases. Moreover, rising government investment in the development of healthcare infrastructure is anticipated to fuel market growth.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Pharmacovigilance Market Companies

Name Profile # Employees HQ Website
BioClinica View profile 1001-5000 Newtown, Pennsylvania, United States, North America http://www.bioclinica.com
FMD K&L View profile 51-100 Fort Washington, Pennsylvania, United States, North America https://clinchoice.com
United Biosource Corporation View profile 1001-5000 Bethesda, Maryland, United States, North America http://ubc.com
ITClinical View profile 11-50 Lisboa, Lisboa, Portugal, Europe https://itclinical.com/
Linical Americas View profile 501-1000 Stuart, Florida, United States, North America https://www.linicalamericas.com
TAKE Solutions View profile 1001-5000 Princeton, New Jersey, United States, North America http://www.takesolutions.com
Capgemini SE View profile 340400 11 rue de Tilsitt, Paris, France, 75017 https://www.capgemini.com
ArisGlobal View profile 1001-5000 Coral Gables, Florida, United States, North America https://www.arisglobal.com
PAREXEL View profile 10001+ Waltham, Massachusetts, United States, North America http://www.parexel.com
IQVIA Holdings Inc View profile 87000 2400 Ellis Road, Durham, NC, United States, 27703 https://www.iqvia.com
Icon PLC View profile 41150 South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 https://www.iconplc.com
Labcorp Holdings Inc View profile 67000 358 South Main Street, Burlington, NC, United States, 27215 https://www.labcorp.com
Cognizant Technology Solutions Corp Class A View profile 344400 300 Frank West Burr Boulevard, Suite 36, 6th Floor, Teaneck, NJ, United States, 07666 https://www.cognizant.com
Accenture PLC Class A View profile 742000 1 Grand Canal Square, Grand Canal Harbour, Dublin, Ireland, 2 https://www.accenture.com
Wipro Ltd ADR View profile 244707 Sarjapur Road, Doddakannelli, Bangalore, KA, India, 560 035 https://www.wipro.com
International Business Machines Corp View profile 282200 One New Orchard Road, Armonk, NY, United States, 10504 http://www.ibm.com

South Korea pharmacovigilance market size, by product life cycle, 2018-2030 (US$M)

South Korea Pharmacovigilance Market Outlook Share, 2024 & 2030 (US$M)

South Korea pharmacovigilance market size, by product life cycle, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online